Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2025-12-25 @ 4:49 AM
NCT ID:
NCT03806218
Eligibility Criteria:
Inclusion Criteria:
* radiologic or pathologic diagnosis of HCC recurrence after locoregional treatment
* HCC nodules measuring 1 cm or larger and smaller than 5 cm
Exclusion Criteria:
* more than three HCC nodules
* tumors with major vascular invasion or abutment to the central portal or hepatic vein with a diameter \> 5mm
* extrahepatic metastasis
* Child-Pugh class C
* severe coagulopathy (platelet cell count of less than 50,000 cells/mm3 or prothrombin time international normalized ratio (PT-INR) prolongation of more than 50 %)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT03806218
Study Brief:
Protocol Section:
NCT03806218